Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis
暂无分享,去创建一个
Brian G. Williams | Christopher Dye | C. Dye | B. Williams | M. Espinal | M. Raviglione | Marcos A. Espinal | Mario C. Raviglione | B. Williams
[1] D. van Soolingen,et al. Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements , 2001, Journal of internal medicine.
[2] N. Binkin,et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[3] R. Reves,et al. Spread of strain W, a highly drug-resistant strain of Mycobacterium tuberculosis, across the United States. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] P E Fine,et al. The long-term dynamics of tuberculosis and other diseases with long serial intervals: implications of and for changing reproduction numbers , 1998, Epidemiology and Infection.
[5] C. Dye,et al. Will tuberculosis become resistant to all antibiotics? , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[6] I. Orme,et al. Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice , 1995, Infection and immunity.
[7] A. Khomenko,et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. , 2000, JAMA.
[8] D. van Soolingen,et al. Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997. , 1999, The Journal of infectious diseases.
[9] S. Svenson,et al. Spread of Drug-Resistant Pulmonary Tuberculosis in Estonia , 2001, Journal of Clinical Microbiology.
[10] S. Blower,et al. The intrinsic transmission dynamics of tuberculosis epidemics , 1995, Nature Medicine.
[11] T. Whittam,et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. Snider,et al. Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli. , 2015, The American review of respiratory disease.
[13] D. van Soolingen,et al. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. , 2000, Emerging infectious diseases.
[14] Jim Y. Kim,et al. Community based approaches to the control of multidrug resistant tuberculosis: introducing “DOTS-plus” , 1998, BMJ.
[15] D. van Soolingen,et al. Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment. , 2001, Emerging infectious diseases.
[16] N. Nagelkerke,et al. Analysis of tuberculosis transmission between nationalities in the Netherlands in the period 1993-1995 using DNA fingerprinting. , 1998, American journal of epidemiology.
[17] P. Small,et al. Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico. , 2000, Archives of internal medicine.
[18] M. Pagano,et al. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[19] S. Blower,et al. Control Strategies for Tuberculosis Epidemics: New Models for Old Problems , 1996, Science.
[20] A. Vernon,et al. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid , 1999, The Lancet.
[21] Rajesh K. Gupta,et al. Responding to Market Failures in Tuberculosis Control , 2001, Science.
[22] K. Kam,et al. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[23] M. Hazbón,et al. Clinical and programmatic mismanagement rather than community outbreak as the cause of chronic, drug-resistant tuberculosis in Buenaventura, Colombia, 1998. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[24] C. Dye,et al. Rational 'DOTS plus' for the control of MDR-TB. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[25] M. Iseman,et al. PITFALLS IN THE CARE OF PATIENTS WITH TUBERCULOSIS: COMMON ERRORS AND THEIR ASSOCIATION WITH THE ACQUISITION OF DRUG RESISTANCE , 1993, JAMA.
[26] Christopher Dye,et al. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. , 2001, The New England journal of medicine.
[27] J. Davies,et al. Bacteria on the rampage , 1996, Nature.
[28] M. Pavlic,et al. Mycobacterium tuberculosis isolates of Beijing genotype in Thailand. , 2001, Emerging infectious diseases.
[29] J. T. Crawford,et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. , 1996, JAMA.
[30] P. Sonnenberg,et al. Tuberculosis control and molecular epidemiology in a South African gold-mining community , 2000, The Lancet.
[31] Annelies Van Rie,et al. Analysis for a Limited Number of Gene Codons Can Predict Drug Resistance of Mycobacterium tuberculosis in a High-Incidence Community , 2001, Journal of Clinical Microbiology.
[32] D. Maher,et al. Guidelines for the Management of Drug-resistant Tuberculosis , 1997 .
[33] L. Karasulu,et al. The treatment of multidrug-resistant tuberculosis in Turkey. , 2001, The New England journal of medicine.
[34] M. Perkins,et al. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[35] G. Turner,et al. Neonatal screening for cystic fibrosis , 2000, The Lancet.